Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 3/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.62 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.62 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.62 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.57 |
| ▸ | FEN1 | P39748 | 1/20 | 0.57 |
| ▸ | CES2 | O00748 | 1/20 | 0.56 |
| ▸ | CES1 | P23141 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 4/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 3/20 | 0.53 |
| ▸ | NPC1 | O15118 | 2/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 2/20 | 0.52 |
| ▸ | CA2 | P00918 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene SCHEMBL27987336 | 0.95 | GSK3B (0.91) | GSK3BALDH1A1HIF1AMAPK1TRPA1 | |
| Formaldehyde SCHEMBL28234403 | 0.95 | GSK3B (0.91) | GSK3BALDH1A1HIF1AMAPK1TRPA1 | |
| SCHEMBL28874706 | 0.93 | GSK3B (0.87) | GSK3BALDH1A1HIF1AMAPK1TRPA1 | |
| SCHEMBL25224307 | 0.93 | GSK3B (0.87) | GSK3BALDH1A1HIF1AMAPK1TRPA1 | |
| SCHEMBL28574433 | 0.89 | GSK3B (0.80) | GSK3BALDH1A1HIF1AMAPK1TRPA1 | |
| SCHEMBL11480265 | 0.89 | GSK3B (0.80) | GSK3BALDH1A1HIF1AMAPK1TRPA1 | |
| SCHEMBL15756687 | 0.88 | GSK3B (0.77) | GSK3BALDH1A1HIF1AMAPK1TRPA1 | |
| SCHEMBL11002539 | 0.83 | ALDH1A1 (0.83) | GSK3BALDH1A1HIF1AMAPK1TRPA1 | |
| SCHEMBL10886301 | 0.82 | GSK3B (0.70) | GSK3BALDH1A1HIF1AMAPK1TRPA1 | |
| SCHEMBL16552727 | 0.82 | GSK3B (0.70) | GSK3BALDH1A1ERCC5FEN1CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 802 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119614529-A | Short-chain dehydrogenase, engineering bacteria and application thereof in asymmetric reduction of potential chiral carbonyl compounds | 杭州文德阶生物科技有限公司 | 2025-03-14 | — | — | CN | claimed |
| CN-117210193-A | Ultraviolet-resistant UV adhesive and preparation method thereof | 广东阿普邦新材料科技股份有限公司 | 2023-12-12 | — | — | CN | claimed |
| CN-116041309-B | Continuous extraction synthesis method of substituted ketal | 浙江宇龙生物科技股份有限公司 | 2023-11-14 | — | — | CN | claimed |
| CN-219168425-U | Production equipment of 2, 4-dichloro acetophenone | 江苏隆昌化工有限公司 | 2023-06-13 | — | — | CN | claimed |
| CN-116041309-A | Continuous extraction synthesis method of substituted ketal | 浙江宇龙生物科技股份有限公司 | 2023-05-02 | — | — | CN | claimed |
| CN-111253233-B | Transposition method of acetophenone isomer | 浙江禾本科技股份有限公司 | 2023-02-28 | — | — | CN | claimed |
| CN-112522224-B | Alcohol dehydrogenase mutant with improved activity and stereoselectivity, recombinant vector, genetic engineering bacteria and application thereof | 华东理工大学 | 2022-12-23 | — | — | CN | claimed |
| CN-113231089-B | Preparation method and application of supported phosphotungstic acid or phosphotungstate solid acid catalyst | 南京工业大学 | 2022-08-30 | — | — | CN | claimed |
| CN-109400541-B | Process for the preparation of cyproconazole from 1-chloro-2- (4-chlorophenyl) -3-methyl-4-penten-2-ol | 淮安国瑞化工有限公司 | 2022-05-17 | — | — | CN | claimed |
| CN-109400542-B | Preparation method of cyproconazole | 淮安国瑞化工有限公司 | 2022-05-13 | — | — | CN | claimed |
| US-20110288315-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE COMPOUND | DAISO CO., LTD. (JP) | 2011-11-24 | — | — | US | claimed |
| CN-101781290-B | New method for producing propiconazole | LIMIN CHEMICAL CO LTD | 2011-11-09 | — | — | CN | claimed |
| CN-102225935-A | Manufacturing method of proPiconazole | SHANDONG WEIFANG SHUANGXING PESTICIDE CO LTD | 2011-10-26 | — | — | CN | claimed |
| EP-2377376-A1 | METHOD TO FORM SOLDER DEPOSITS ON SUBSTRATES | ATOTECH Deutschland GmbH (DE) | 2011-10-19 | — | — | EP | claimed |
| US-20110189848-A1 | METHOD TO FORM SOLDER DEPOSITS ON SUBSTRATES | ATOTECH DEUTSCHLAND GMBH & CO. KG (F/K/A ATOTECH DEUTSCHLAND GMBH) (DE) | 2011-08-04 | — | — | US | claimed |
| EP-2325178-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE COMPOUND | DAISO CO., LTD. (JP) | 2011-05-25 | — | — | EP | claimed |
| CN-101781290-A | New method for producing propiconazole | LIMIN CHEMICAL CO LTD | 2010-07-21 | — | — | CN | claimed |
| WO-2010046235-A1 | METHOD TO FORM SOLDER DEPOSITS ON SUBSTRATES | ATOTECH DEUTSCHLAND GMBH (DE) | 2010-04-29 | — | — | WO | claimed |
| CN-101323612-A | Preparation of bactericide propiconazole | JIANGSU SEVENCONTINENT GREEN C (CN) | 2008-12-17 | — | — | CN | claimed |
| US-4417957-A | CHLORINATED ACETOPHENONES; ACRYLIC ACID AND/OR METHACRYLIC ACID | COLUMBIA CHEMICAL CORPORATION (US) | 1983-11-29 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110288315-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE COMPOUND | CYP51A1, KMO, TALDO1 | GSK3B 776/4885ALDH1A1 453/4885HIF1A 1833/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.